montelukast msd 10 mg filmtabletten
merck sharp & dohme gesellschaft mbh - montelukast natrium - montelukast
ezetimib/atorvastatin msd 10 mg/10 mg filmtabletten
merck sharp & dohme b.v. - atorvastatin calcium trihydrat; ezetimib -
ezetimib/atorvastatin msd 10 mg/20 mg filmtabletten
merck sharp & dohme b.v. - atorvastatin calcium trihydrat; ezetimib -
ezetimib/atorvastatin msd 10 mg/40 mg filmtabletten
merck sharp & dohme b.v. - atorvastatin calcium trihydrat; ezetimib -
ezetimib/atorvastatin msd 10 mg/80 mg filmtabletten
merck sharp & dohme b.v. - atorvastatin calcium trihydrat; ezetimib -
trommsdorff schmerzcreme
trommsdorff gmbh & co. kg (3086350) - pfefferminzöl; eucalyptusöl ((mit angaben zur herkunft)); rosmarinöl - creme - teil 1 - creme; pfefferminzöl (00251) 0,625 gramm; eucalyptusöl ((mit angaben zur herkunft)) (00123) 0,625 gramm; rosmarinöl (01258) 0,4 gramm
montelukast msd 5 mg kautabletten
merck sharp & dohme gesellschaft mbh - montelukast natrium - montelukast
montelukast msd 4 mg granulat
merck sharp & dohme gesellschaft mbh - montelukast natrium -
montelukast msd 4 mg kautabletten
merck sharp & dohme gesellschaft mbh - montelukast natrium -
cancidas (previously caspofungin msd)
merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimykotika zur systemischen anwendung - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.